C12N 9/24
Acting on glycosyl compounds
Official title: acting on glycosyl compounds (3.2)
C12N9/24 (Acting on glycosyl compounds) appears on 5,530 US grants and 7,023 published applications in this corpus.
Search patents in C12N- Granted patents
- 5,530
- Published applications
- 7,023
- Assignees
- 2,280
- Inventors
- 11,999
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 14 | 0 |
| 1977 | 9 | 0 |
| 1978 | 10 | 0 |
| 1979 | 5 | 0 |
| 1980 | 11 | 0 |
| 1981 | 10 | 0 |
| 1982 | 11 | 0 |
| 1983 | 8 | 0 |
| 1984 | 23 | 0 |
| 1985 | 14 | 0 |
| 1986 | 20 | 0 |
| 1987 | 26 | 0 |
| 1988 | 26 | 0 |
| 1989 | 25 | 0 |
| 1990 | 38 | 0 |
| 1991 | 32 | 0 |
| 1992 | 30 | 0 |
| 1993 | 40 | 0 |
| 1994 | 54 | 0 |
| 1995 | 64 | 0 |
| 1996 | 71 | 0 |
| 1997 | 116 | 0 |
| 1998 | 175 | 0 |
| 1999 | 158 | 0 |
| 2000 | 138 | 0 |
| 2001 | 168 | 18 |
| 2002 | 118 | 147 |
| 2003 | 114 | 217 |
| 2004 | 60 | 155 |
| 2005 | 62 | 160 |
| 2006 | 125 | 148 |
| 2007 | 77 | 123 |
| 2008 | 92 | 144 |
| 2009 | 74 | 222 |
| 2010 | 124 | 224 |
| 2011 | 145 | 272 |
| 2012 | 184 | 310 |
| 2013 | 188 | 320 |
| 2014 | 258 | 404 |
| 2015 | 243 | 378 |
| 2016 | 249 | 364 |
| 2017 | 250 | 353 |
| 2018 | 242 | 303 |
| 2019 | 260 | 386 |
| 2020 | 248 | 350 |
| 2021 | 224 | 370 |
| 2022 | 210 | 331 |
| 2023 | 159 | 341 |
| 2024 | 201 | 360 |
| 2025 | 185 | 368 |
| 2026 | 142 | 255 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Disruption of CD28-sialoside ligand complexes to enhance T cell activation6 Oct 2026US 12,752,014 B2The Scripps Research Institute
- Alpha-amylase variants and polynucleotides encoding same6 Oct 2026US 12,753,399 B2Novozymes A/S
- Alpha-amylase variants6 Oct 2026US 12,753,400 B2Novozymes A/S
- Cleaning compositions comprising dispersins VI29 Sep 2026US 12,747,416 B2Henkel AG & Co. KGaA
- Expression of nitrogenase polypeptides in plant cells29 Sep 2026US 12,747,428 B2Commonwealth Scientific and Industrial Research Organisation
- Combination of nonmaltogenic exoamylase and glucoamylase for improving bread resilience and reducing amount of added sugars8 Oct 2026US 2026/0305625 A1International N&H Denmark Aps
- Method for producing plant-based cheese8 Oct 2026US 2026/0305639 A1Amano Enzyme Inc.
- Novel base editors and uses thereof8 Oct 2026US 2026/0308552 A1Huidagene Therapeutics (Singapore) Pte. Ltd.
- Xylanase variants and polynucleotides encoding same8 Oct 2026US 2026/0308558 A1Novozymes A/S
- Methods of increasing sialic acid levels in recombinant glycosylated proteins8 Oct 2026US 2026/0308601 A1Denali Therapeutics Inc.
Most cited
By later US patents
- Methods for in vitro recombination882US 5,605,793 AAffymax Technologies N.V. · 1997
- Methods and compositions for cellular and metabolic engineering844US 5,837,458 AMaxygen, Inc. · 1998
- DNA mutagenesis by random fragmentation and reassembly791US 5,830,721 AAffymax Technologies N.V. · 1998
- Methods for generating polynucleotides having desired characteristics by iterative selection and recombination707US 5,811,238 AAffymax Technologies N.V. · 1998
- Methods for generating polynucleotides having desired characteristics by iterative selection and recombination531US 6,117,679 AMaxygen, Inc. · 2000